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Variability in growth characteristics of influenza B viruses remains a serious limitation in the manufacture of inactivated influenza vaccines.
Currently, serial passage in eggs is the strategy used in most instances for selection of high growth virus variants. In previous studies we found that
adaptation of the strain B/Victoria/504/2000 to high growth in eggs was associated with changes only in hemagglutinin (HA). The high growth
phenotype was associated with acquisition of either two (R162M and D196Y) or three (G141E, R162M and D196Y) amino acid (AA)
substitutions, predicted to be near the receptor-binding domain of HA. In the present study we analyzed, using reverse genetics, the contribution to
virus growth of each of these AA substitutions and determined their effect on antigenic properties. We found that G141E and R162M were most
favorable for virus growth; however, only R162M could improve virus growth without antigenic alteration. Substitution D196Y had least effect on
virus growth but substantially altered antigenic properties. Additional virus variants with AA substitutions at positions 126, 129, 137 and 141 were
generated and characterized. The AA changes advantageous for growth of B/Victoria/504/2000 were also tested in the context of the HA of the B/
Beijing/184/93, a virus with stable low-growth phenotype. All of the tested AA substitutions improved the replicative capabilities of the
corresponding viruses, but only N126D and K129E had no effect on antigenicity. The results of our studies demonstrate that introduction of
specific AA substitutions into viral HA can improve viral replicative efficiency while preserving the original antigenic properties.
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Influenza A and B viruses cause seasonal epidemics
associated with morbidity, mortality and economic loss (Cox
and Subbarao, 1999; Simonsen et al., 2000; Thompson et al.,
2004). Vaccination remains the primary means of influenza
prophylaxis and control. Currently licensed inactivated influ-
enza vaccines are trivalent formulations that contain antigenic
components of two subtypes of influenza A virus (H1N1 and⁎ Corresponding author. Fax: +1 301 402 5128.
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doi:10.1016/j.virol.2007.04.006H3N2) and one influenza B virus. The high rate of mutation and
antigenic drift of influenza viruses require continuous epide-
miological surveillance and annual reconsideration of influenza
vaccine composition in order to assure that the vaccine virus
strains are antigenically representative of natural field isolates.
In case of selection of new vaccine virus strains, they have to be
adapted to provide high yield in embryonated chicken eggs
(eggs), the primary substrate for vaccine production. Influenza
virus strains vary in their capability to replicate in eggs and low
virus yield in eggs remains a serious problem in the manufacture
of influenza vaccines. Conventional genetic reassortment
technology, which has been successfully used for influenza A
viruses for decades, has not been as successful for influenza B
viruses (Goodeve et al., 1985; Kilbourne, 1969; Robertson et
al., 1992; Vodeiko et al., 2003). Even when all six of the
genome segments encoding for viral proteins other than the
Table 1
Phenotypic characteristics of the B/Victoria/504/2000 variants differing at AA
positions 141, 162 and 196 of HA
Virus a AA at position Infectious titers,
log10/0.1 ml±SD
b
HA
titer c
Mean
plaque
size (mm)±
SDb
141 162 196 EID50 TCID50
Variant-1 G R D 7.4±0.1 6.7±0.2 128 0.9±0.4
Variant-2 E M Y 8.9±0.3 8.8±0.1 2048 2.2±0.3
Variant-3 E 8.4±0.3 8.7±0.1 1024 1.7±0.5
Variant-4 Y 7.8±0.1 7.2±0.2 128 0.5±0.2
Variant-5 M 8.3±0.1 8.2±0.2 512 1.5±0.4
Variant-6 E Y 8.6±0.3 8.8±0.1 1024 1.8±0.6
Variant-7 E M 8.6±0.3 8.6±0.4 1024 1.8±0.4
Variant-10 M Y 8.6±0.3 8.4±0.4 1024 1.4±0.4
a All viruses were generated using reverse genetics. The nucleotide sequences
of all eight genome segments of Variant-1 are identical to the corresponding
consensus sequences of the natural reference strain B/Victoria/504/2000; other
variants differ by AA substitutions introduced into their HAs.
b Data represent the mean (±standard deviations) of three independent
experiments. P<0.02 for all comparisons versus Variant-1.
c Titers are expressed as the reciprocal of the highest virus dilution producing
hemagglutination (see Materials and methods for details).
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high growth strains, the resulting reassortant viruses rarely
exhibit improved growth characteristics. This fact is comple-
mented by the observation that adaptation of influenza B viruses
to high growth in eggs may be associated with amino acid
substitutions in viral HA (Gambaryan et al., 1999; Govorkova et
al., 1999a, 1999b; Lugovtsev et al., 2005; Oxford et al., 1990;
Robertson et al., 1985, 1990, 1993; Saito et al., 2004; Wagner et
al., 2002; Williams and Robertson, 1993).
In previous studies of the strain B/Victoria/504/2000, we
found that adaptation to high growth in eggs was associated
only with AA substitutions in HA (Lugovtsev et al., 2005). Two
independently isolated virus variants adapted by consecutive
passage in eggs acquired either two AA substitutions (R162M
and D196Y) or three AA substitutions (G141E, R162M and
D196Y), respectively, predicted to be near the receptor-binding
domain of HA. Both variants exhibited significantly increased
virus yields in eggs compared to the B/Victoria/504/2000
reference virus from which they were derived, with the virus
variant containing all three substitutions demonstrating the best
growth characteristics. At the same time both variants showed
the noticeable divergence from the original virus by antigenic
properties. In the present study, we expand current knowledge
of the contribution of those AA substitutions in HA to virus
growth characteristics and other phenotypic properties. We used
reverse genetics to generate a series of B/Victoria/504/2000
virus variants with the genome identical to the consensus
sequence of the reference strain B/Victoria/504/2000, but
differing between each other only by the presence or absence
of the targeted AA substitutions in their HAs. In addition to the
previously identified AA changes, a range of other AA
substitutions, introduced in proximity to the receptor-binding
domain of the HA (AA positions 126, 129, 137 and 141), were
tested for their effect on viral phenotype. Finally, we
demonstrated that the AA substitutions beneficial for growth
capability of the strain B/Victoria/504/2000 had similar effect
when introduced into the HA of the B/Beijing/184/93, a strain
with stable low-growth phenotype.
Results
Effect of substitutions G141E, R162M and D196Y on viral
growth characteristics
Eight B/Victoria/504/2000-like virus variants, distinguished
only by AA substitutions at positions 141, 162 and 196 in
their HAs, were generated and characterized (Table 1). As we
found in our previous study (Lugovtsev et al., 2005), virus
with all three AA substitutions (variant #2) demonstrated the
best growth characteristics and the highest titer of hemagglu-
tination (1:2048), and also produced large plaques in MDCK.
However, viruses even with a single substitution G141E
(variant #3) or R162M (variant #5) also exhibited a significant
growth improvement in eggs and MDCK, and increased titers
of hemagglutination (1:1024 and 1:512, respectively), forming
medium-size plaques in MDCK. Substitution D196Y (variant
#4) contributed least to replication, failed to increase thehemagglutination titer (1:128) and resulted in the formation of
small plaques in MDCK. Although all double-mutant viruses
(variants #6, #7 and #10) showed high growth phenotype,
none of them had a yield in eggs significantly higher than
single-mutant viruses having either G141E or R162M. Variant
#1 (containing unmodified HA), like its natural counterpart,
reference virus B/Victoria/504/2000 (data not shown), exhib-
ited low-growth phenotype in eggs and MDCK.
Effect of substitutions G141E, R162M and D196Y on viral
antigenic properties
The antigenic properties of the generated viruses were tested
by hemagglutination inhibition assay (HI) (Table 2). Ferret sera
against natural reference strain B/Victoria/504/2000 and seven
plasmid-derived virus variants were used. All viruses with
modified HAs were evaluated in comparison with variant #1,
which had the HA of the reference virus. Among the viruses
with a single AA substitution, variant #4 (D196Y) showed
strongest antigenic divergence from non-mutated virus (variant
#1). On the other hand, the substitution R162M had minimal
effect on antigenic properties, and the resultant virus (variant
#5) was the only one antigenically indistinguishable from the
reference variant #1 (≤2-fold difference of the corresponding
HI titers). Variant #3 (G141E) demonstrated moderate antigenic
divergence.
All virus variants having more than one AA substitution
were antigenically distinguishable from the reference variant #1
containing unmodified HA (≥4-fold difference of the corre-
sponding HI titers). The most divergent antigenic patterns were
observed for viruses containing AA substitution D196Y, espe-
cially in combination with G141E (variants #6 and #2). Variant
#7 (G141E and R162M) showed moderate antigenic deviation,
similar to that of variant #3 containing single substitution
Table 2
HI titers of antisera raised against B/Victoria/504/2000 variants differing at AA positions 141, 162 and 196 of HA
Virus a AA at position Antiserum
141 162 196 B/Vict/504 b Variant-2 Variant-3 Variant-4 Variant-5 Variant-6 Variant-7 Variant-10
Variant-1 G R D 128 c 32 64 32 1024 512 512 128
Variant-2 E M Y 128 512 256 256 512 4096 2048 256
Variant-3 E 128 128 256 64 512 2048 2048 128
Variant-4 Y 128 128 32 256 256 2048 512 256
Variant-5 M 128 32 64 64 1024 512 1024 128
Variant-6 E Y 128 512 128 256 256 4096 2048 256
Variant-7 E M 128 128 256 64 1024 1024 2048 128
Variant-10 M Y 128 256 32 256 512 2048 512 512
a All viruses were generated using reverse genetics. The nucleotide sequences of all eight genome segments of Variant-1 are identical to the corresponding consensus
sequences of the natural reference strain B/Victoria/504/2000; other variants differ by AA substitutions introduced into their HAs.
b This serum was obtained from the ferret infected by the natural reference strain B/Victoria/504/2000; other sera were obtained from the ferrets infected by the
corresponding reverse genetics-generated viruses.
c Reciprocal of the highest dilution of serum capable of completely inhibit HA activity of the respective virus variant; homologous titers are in bold. Data are shown
from a representative experiment with four replicates for each serum sample.
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combinations.
Effect of different amino acids at position 141 on viral
phenotype
The results in the previous sections clearly demonstrate that
each of the individual AA substitutions varies in degree of their
effect on viral phenotype characteristics. Although substitutions
G141E and R162M both contributed to high growth phenotype,
G141E is less desirable due to a significant influence on
antigenic properties. To further investigate the functional
significance of AA 141, three other viruses varying by AA at
position 141 were generated and characterized (Table 4: variants
#43, #44 and #45). The effect of the selected AA was tested in
the context of the combination of two other AA substitutions
(R162M and D196Y) beneficial to virus growth, which
naturally occurred in two independently selected high-growth
variants (Lugovtsev et al., 2005).
The G141K substitution of variant #43 retained a hydrophilic
state, but provided net positive charge. In contrast, the G141Y
substitution of variant #44 imparted strong hydrophobicity but
did not alter net electrostatic charge. The G141L substitution of
variant #45 provided a hydrophobic state without alteration of
charge and polarity. Among five tested virus variants, differing
only by AA at position 141 (variants #2, #10, #43, #44 and
#45), variants #2 and #45 (containing either G141E or G141L,
respectively) showed best growth characteristics, demonstrating
highest hemagglutination titers, high virus yield in eggs and
comparatively high infectivity for MDCK, where they produced
plaques of large size. In contrast, neither lysine (variant #43) nor
tyrosine (variant #44) at position 141 was beneficial for virus
yield in eggs (P<0.05). Both viruses had limited viral
infectivity for MDCK (P<0.05), and were also characterized
by very small (pinpoint) plaques (P<0.001).
Serological studies indicated that among four tested alter-
natives to glycine the substitution G141E (variant #2) was
found to be least detrimental for antigenic properties compared
to variant #10, which has a naturally conserved glycine at thisposition (Table 4). In contrast, variants #43, #44 and #45 (with
G141K, G141Y and G141L, respectively) demonstrated altered
antigenic properties (≥4-fold difference of HI titers of at least
one antiserum).
Effect of amino acid substitutions at positions 126, 129 and
137 on viral growth and antigenic characteristics
Although specific AA at position 141 strongly associated
with the viral growth phenotype, the replacement of glycine by
other AA residues resulted in altered antigenic properties.
Therefore, we further investigated whether AA substitutions in
other positions could be beneficial for growth but with minimal
effect on antigenic properties. The selected AA residues were
predicted to be on the surface of HA molecule and in proximity
to the receptor-binding domain. Because all modifications were
evaluated on the background of two other AA substitutions,
R162M and D196Y, the resulting viruses were compared to
variant #10 (Table 3).
AA position 137 is usually occupied by either leucine or
isoleucine and, in fewer instances, by valine. In this study two
viruses containing substitutions L137K (variant #46) or L137E
(variant #47) were generated (Table 3). Although neither of the
substitutions had significant effect on virus growth in eggs, both
reduced virus infectivity for MDCK (P<0.001 and P<0.02 for
variants #46 and #47, respectively). Variant #46 with L137K
was antigenically indistinguishable from variant #10 (which has
original leucine at position 137) (Table 4). In contrast glutamic
acid altered the antigenic profile of variant #47 (≥4-fold
difference of HI titers of at least one antiserum) (Table 4).
AA changes at position 129, usually occupied by lysine or
arginine, and position 126, usually occupied by asparagine or
aspartic acid, were also studied (Tables 3 and 4). Modification
by introduction of a glutamic acid at position 129 (K129E,
variant #48) contributed to higher hemagglutination titers
(1:2048) and big plaques in MDCK (P<0.001), but affected
antigenic characteristics. Introduction of glycine (K129G,
variant #50) did not affect antigenicity, but was not beneficial
for virus growth either. Substitution N126D had minimal effect
Table 3
Phenotypic characteristics of the B/Victoria/504/2000 variants with AA substitutions at positions 126, 129, 137 and 141 of HA
Virus a AA at position Infectious titers, log10/
0.1 ml±SDb
HA
titer c
Mean
plaque
size (mm)±
SDb
126 129 137 141 162 196 EID50 TCID50
Variant-1 N K L G R D 7.4±0.1* 6.7±0.2* 128 0.9±0.4*
Variant-10 M Y 8.6±0.3 8.4±0.4 1024 1.4±0.4
Variant-2 E M Y 8.9±0.3 8.8±0.1* 2048 2.2±0.3*
Variant-43 K M Y 7.6±0.5* 7.7±0.2* 256 0.2±0.1*
Variant-44 Y M Y 7.8±0.3* 6.6±0.3* 256 0.4±0.2*
Variant-45 L M Y 8.6±0.4 7.7±0.4 2048 2.2±0.5*
Variant-46 K M Y 8.2±0.5 5.9±0.3* 512 1.3±0.4
Variant-47 E M Y 8.1±0.4 7.5±0.2* 1024 2.3±0.4*
Variant-48 E M Y 8.7±0.1 8.0±0.3 2048 2.1±0.3*
Variant-50 G M Y 8.2±0.3 7.6±0.1* 1024 1.6±0.5
Variant-52 D M Y 8.1±0.1 8.2±0.4 1024 1.7±0.3*
Variant-54 D E M Y 8.4±0.5 8.3±0.5 2048 2.7±0.4*
Variant-56 D G M Y 8.5±0.1 7.6±0.4* 1024 2.6±0.5*
a See footnotes of Table 1 for details.
b Data represent the mean (±standard deviations) of three independent experiments. Asterisks indicate differences that are statistically significant versus Variant-10
(*P<0.05).
c See footnotes of Table 1 for details.
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though increased plaque size in MDCK (P<0.05).
Application of the selected AA substitutions to improve growth
characteristics of B/Beijing/184/93
To investigate whether AA substitutions that promote growth
in eggs of the B/Victoria/504/2000 have similar effects on the
growth of other influenza B viruses, selected AA substitutions
were introduced into the HA of low-growth B/Beijing/184/93.
The effect of the HA modifications was tested on plasmid-
derived reassortant viruses containing two gene segments
encoding HA and NA/NB from B/Beijing/184/93 and sixTable 4
Antigenic patterns of the B/Victoria/504/2000 variants with AA substitutions at pos
Virus a AA at position Antisera
126 129 137 141 162 196 B/Vict/50
Variant-1 N K L G R D 128 c
Variant-10 M Y 128
Variant-2 E M Y 128
Variant-43 K M Y 64
Variant-44 Y M Y 64
Variant-45 L M Y 128
Variant-46 K M Y 128
Variant-47 E M Y 512
Variant-48 E M Y 256
Variant-50 G M Y 128
Variant-52 D M Y 128
Variant-54 D E M Y 512
Variant-56 D G M Y 128
a See footnotes of Table 2 for details.
b Sera were obtained from ferrets infected by the corresponding natural referenc
Panama/45/90 (B/Pan/45) and B/Guangdong/4/91 (B/Gd/4), and reverse genetics-ge
c See footnotes of Table 2 for details.gene segments encoding internal proteins of B/Victoria/504/
2000 (Tables 5 and 6). Variant #14, containing the unmodified
HA of B/Beijing/184/93, demonstrated growth phenotype
similar to that of the original strain B/Beijing/184/93 (data not
shown), with low yield in eggs and MDCK and low titers of
hemagglutination (Table 5).
Single substitution K129E in the HA of B/Beijing/184/93
(variant #71) had a significant impact on virus growth in eggs,
imparting the resulting virus the capabilities to reach 8.5 log10
EID50/0.1 ml, that is more than two orders of magnitude higher
than variant #14 with the HA of the reference virus (P<0.001).
However, the titers of hemagglutination and infectivity for
MDCK increased only moderately. Similar to the virus withitions 126, 129, 137 and 141 of HA investigated by HI test
b
4 Variant-10 Variant-2 B/Beij/184 B/Pan/45 B/Gd/4
64 32 64 64 256
256 128 64 64 64
256 256 128 64 64
64 64 32 32 16
128 128 32 8 32
256 256 64 16 64
512 256 64 64 64
2048 512 256 256 256
1024 512 128 256 256
512 256 64 128 128
512 256 64 128 128
1024 512 256 256 256
256 256 128 128 128
e strains: B/Victoria/504/2000 (B/Vict/504), B/Beijing/184/93 (B/Beij/184), B/
nerated viruses, Variant-2 and Variant-10.
Table 5
Phenotypic characteristics of the B/Beijing/184/93-like variants differing at AA positions 126, 129, 137 and 141 of HA
Virus a AA at position Infectious titers, log10/
0.1 ml±SDb
HA
titer c
Mean plaque size
(mm)±SDb
126 129 137 141 EID50 TCID50
Variant-14 N K L G 6.2±0.3 6.0±0.3 64 0.8±0.5
Variant-71 E 8.5±0.4* 7.0±0.2* 256 0.9±0.3
Variant-72 D E 8.0±0.1* 7.3±0.7* 256 0.9±0.4
Variant-73 E E 8.2±0.3* 7.8±0.4* 1024 1.2±0.5*
Variant-74 E 8.2±0.3* 7.6±0.4* 512 1.1±0.4*
Variant-75 D 7.5±0.2* 5.8±0.3 128 0.5±0.3*
Variant-76 D E 8.1±0.1* 8.4±0.6* 256 1.8±0.5*
Variant-77 G E 8.0±0.1* 7.9±0.6* 256 1.1±0.3*
Variant-78 D G E 8.5±0.3* 8.3±0.1* 512 1.2±0.4*
a All variants are reverse genetics-generated 6:2 reassortant viruses containing HA and NA/NB genome segments from B/Beijing/184/93 and six other segments
from B/Victoria/504/2000. The nucleotide sequences of HA and NA/NB genome segments of Variant-14 are identical to the corresponding consensus sequences of the
natural reference strain B/Beijing/184/93; other variants differ by AA substitutions introduced into their HAs.
b Data represent the mean (±standard deviations) of two or more independent experiments. Asterisks indicate differences that are statistically significant versus
Variant-14 (*P<0.05).
c Titers are expressed as the reciprocal of the highest virus dilution producing hemagglutination (see Materials and methods for details).
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medium plaques in MDCK. Serological studies revealed that
substitution K129E had no effect on the viral antigenic
properties (Table 6).
Virus variant #72 combining two AA changes, N126D and
K129E, demonstrated no advantages compared with variant
#71. Even though substitution N126D (variant #75) had least
effect on growth properties compared to other variants, and was
associated with a low virus infectivity for MDCK and small-
plaque phenotype, it still had positive effect on viral yield in
eggs (P<0.001), and did little to affect antigenic properties
(≤2-fold difference of the corresponding HI titers of all used
antisera).
Substitution G141E (variant #74) improved virus growth
capabilities (P<0.001) and contributed to high hemagglutina-
tion titers (1:512). Addition of L137E to G141E (variant #73)
did not intensify the effect provided byG141E on virus yield, but
resulted in highest titers of hemagglutination (1:1024) observedTable 6
Antigenic patterns of the B/Beijing/184/93-like variants investigated by HI test
Virus a AA in HA protein Antisera b
126 129 137 141 B/Beij/184 Va
Variant-14 N K L G 256 c 25
Variant-71 E 256 25
Variant-72 D E 256 25
Variant-73 E E 512 51
Variant-74 E 128 25
Variant-75 D 256 12
Variant-76 D E 64 25
Variant-77 G E 64 51
Variant-78 D G E 128 51
a All variants are reverse genetics-generated 6:2 reassortant viruses containing HA
from B/Victoria/504/2000. The nucleotide sequences of HA and NA/NB genome segm
natural reference strain B/Beijing/184/93; other variants differ by AA substitutions i
b Sera were obtained from ferrets infected by the corresponding natural reference s
Panama/45/90 (B/Pan/45), and reverse genetics-generated viruses Variant-71, Varian
c See footnotes of Table 2 for details.for B/Beijing/184/93-like variants. In the case of both variants
the HA modification was associated with antigenic alteration.
Addition of substitution N126D to G141E (variant #76) did
not affect the high yield in eggs provided by G141E alone, but
had a slight positive effect on virus replication in MDCK,
supporting formation of the biggest plaques (1.8±0.5 mm,
P=0.001) compared with other B/Beijing/184/93-like virus
variants. At the same time, titers of hemagglutination of this
virus reached only a moderate level (1:256). No additional
influence was observed from substitutionK129G combinedwith
G141E (variant #77), or of both N126D and K129G combined
with G141E (variant #78). However, all virus variants contain-
ing G141E exhibited antigenic divergence (Tables 5 and 6).
Discussion
Like most influenza B virus isolates the original human
isolate B/Victoria/504/2000 (even after two passages in eggs)riant-71 Variant-72 Variant-73 B/Vict/504 B/Pan/45
6 512 128 32 64
6 512 128 32 64
6 512 128 32 64
2 512 512 32 32
6 256 256 16 16
8 256 128 16 32
6 256 256 16 <16
2 512 256 16 16
2 512 512 16 16
and NA/NB genome segments from B/Beijing/184/93 and six other segments
ents of Variant-14 are identical to the corresponding consensus sequences of the
ntroduced into their HAs.
trains: B/Beijing/184/93 (B/Beij/184), B/Victoria/504/2000 (B/Vict/504) and B/
t-72 and Variant-73.
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ISDN20057, Influenza Sequence Database; Macken et al.,
2001) composing a potential site of glycosylation (196N–
198T). It is known that adaptation of influenza B virus isolates
to replication in eggs is usually associated with a loss of this
glycosylation site, often at the expense of substitution of
aspartic acid for asparagine at position 196 (Oxford et al., 1990;
Robertson et al., 1985, 1990, Saito et al., 2004). The reference
virus B/Victoria/504/2000 used in our studies was received at
egg passage level 13, at which the substitution N196D had
already occurred. However, 17 additional egg passages selected
two high-growth variants during which AA substitution
occurred again at the same position (D196Y) along with either
one (R162M) or two (G141E and R162M) additional AA
changes (Lugovtsev et al., 2005). In the present study, we
examined the effects of each of these three AA substitutions
(singly or in combinations) on the virus growth characteristics
and antigenic properties. Using reverse genetics technology, we
generated eight B/Victoria/504/2000 variants with genome
composition identical to that of reference strain B/Victoria/504/
2000, but differing between each other only by the presence or
absence of the targeted AA substitutions in their HAs (Table 1).
Phenotypic characterization of these virus variants revealed
that each AA substitution had a different effect. AA substitution
D196Y had minimal effect on virus growth phenotype, but a
large impact on antigenic properties. Both substitutions, G141E
and R162M, improved the virus growth, but had different
consequences for antigenic characteristics: G141E altered the
antigenicity whereas R162M did not.
Positions 141 and 162 are both in conserved motifs (AA
138–145 and 155–162, respectively) associated with the
structure of the receptor-binding site (Eisen et al., 1997; Krystal
et al., 1982, 1983; Lamb and Krug, 2001; Matrosovich et al.,
1993; Tung et al., 2004; Verhoeyen et al., 1983; Wilson et al.,
1981), and also adjoin potential sites of glycosylation (145N–
147T and 164N–166T, respectively). It has been suggested that
AA 138–142 of the HA of influenza B viruses correspond to a
conserved motif of HA of influenza A viruses (AA 134–138,
influenza A numbering) (Matrosovich et al., 1993; Nobusawa et
al., 1991) which directly interacts with sialic acid (Weis et al.,
1988), the receptor for influenza A and B viruses. Although
potential involvement of the AA residue at position 141 in
receptor/host specificity and antigenic properties has been
previously discussed, only one type of AA substitution, G141R,
has been studied in greater detail (Nakagawa et al., 2003;
Oxford et al., 1990; Xu et al., 1996). To expand our knowledge
about importance of AA 141, we generated three other viruses
containing different AA residues at this position. Lysine,
tyrosine and leucine were selected to provide alternatives to
the physical and chemical properties of glutamic acid. In spite of
the fact that all AA changes at position 141 were tested in the
context of two other substitutions beneficial to virus replication
(R162M and D196Y), substitutions at position 141 had a variety
of consequences. Either lysine or tyrosine at position 141
(variants #43 and #44, respectively) significantly impaired virus
growth, almost completely eliminating the positive effect
provided by R162M and D196Y. On the other hand, substitu-tion of leucine (variant #45) supported high growth phenotype
similar to that observed for the virus containing glutamic acid at
position 141 (variant #2). Regardless of the effect on growth
phenotype, all variants with AA substitutions at position 141
exhibited antigenic changes. It is reasonable to suggest that any
replacement of glycine at position 141 might alter the steric
features of the HA affecting the antigenic site. Therefore, we
investigated whether AA substitutions at other positions could
amplify the growth-contributing effect of naturally selected
R162M and D196Y.
Taking into account that most of the growth-contributing AA
substitutions were also associated with an alteration of the local
electrostatic charge near the receptor-binding site of the HA, we
tested analogous AA substitutions at AA positions 126, 129,
and 137, predicted to surround the receptor-binding site of HA
(Matrosovich et al., 1993). AA 137 is usually occupied either by
leucine (B/Yamagata/16/88 lineage) or by isoleucine (B/
Victoria/2/87 lineage) and in fewer instances by valine.
Arginine at position 137 (G137R) has also been observed in a
virus passed sequentially through mammalian cells and eggs
(Govorkova et al., 1999b). Although lysine or glutamic acid at
AA 137 has not been documented for natural isolates, both
substitutions tested in the present study (L137K or L137E) were
viable and remained stable in the viruses for at least three
passages in eggs (period of observation). However, neither of
the substitutions enhanced the effect of R162M and D196Y. In
contrast to the lysine, introduction of glutamic acid resulted in
altered antigenic profile.
In natural virus isolates, basic AAs, lysine or arginine,
occupy position 129. Surprisingly, elimination of the positive
charge by introducing a glutamic acid residue (K129E, variant
#48) still supported high viral yield, but also caused antigenic
divergence. Though a switch to glycine (variant #50) did not
affect antigenicity, it was not beneficial for virus growth either.
AA position 126 is usually occupied by either asparagine or
aspartic acid, but neither of them rendered the virus a replicative
advantage. Although it was shown earlier that substitution
N126D together with L58F resulted in an antigenic deviation
(Nakagawa et al., 2002, 2003), we observed no antigenic
alteration associated with N126D.
Both B/Victoria/504/2000 and B/Beijing/184/93 belong to
the B/Yamagata/16/88 antigenic lineage, and their HAs share an
identical AA sequence in a stretch of 31 amino acids (AA 117–
148) which is involved in the formation of antigenic sites and
functional domains. We found that AA substitutions beneficial
to growth in eggs of the B/Victoria/504/2000 had similar effects
on the growth of B/Beijing/184/93, a strain notable for poor
growth characteristics (Vodeiko et al., 2003; WHO, 2000). All
B/Beijing/184/93-like variants with modified HAs (variants
##71–78) showed improved growth capabilities. All variants
containing G141E had altered antigenicity, similar to the
observation for corresponding B/Victoria/504/2000-like var-
iants. In the context of the B/Beijing/184/93 HA composition,
single substitution K129E (variant #71) had an appreciable
impact on virus growth, significantly increasing the virus yield
in eggs. Notably, this improvement did not have an effect on
antigenic properties. Evaluation of the N126D in the HA of B/
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antigenic insignificance, but, at the same time, clearly demon-
strated its beneficial effect on viral yield in eggs, though not so
conspicuous if compared with the effects of other AA changes.
As had been shown previously, adaptation of influenza A
and B viruses to replicate in eggs is often associated with AA
substitutions located near the receptor-binding domain of HA,
resulting in an alteration of the local charge of the molecule,
mostly to the basic side (Govorkova et al., 1999b; Hardy et al.,
1995; Katz et al., 1987; Kodihalli et al., 1995; Robertson et al.,
1987, 1993). It has been suggested that accruing positive charge
may increase nonspecific ionic interactions between virus
particles and negatively charged cellular receptors (Gambaryan
et al., 1999). However, our results are more consistent with the
opposite mechanism, observed in studies of influenza Aviruses,
suggesting that increase in the negative charge in the vicinity of
the receptor-binding pocket leads to an electrostatic repulsion
between the virus particles and the macromolecules on the cell
surface surrounding the sialic receptor (Gambaryan et al., 1998;
Kaverin et al., 2000).
The results presented in this study demonstrate that growth
characteristics of influenza B virus strains can be altered greatly
by specific changes of the viral surface glycoprotein HA. The
results also show that subtle modification of the viral HA by
carefully selecting one or a fewAA substitutions can significantly
improve viral replicative efficiency but preserve the original
antigenic properties. The ability to identify and alter the crucial
AAs indicates an approach that could substantially expedite the
preparation of high-growth virus variants needed for vaccine
production within limits of time and could help to achieve the
priority goal to increase influenza vaccine availability.
Materials and methods
Viruses and growth substrates
Reference influenza viruses B/Victoria/504/2000 and B/
Beijing/184/93 were received from the Centers for Disease
Control and Prevention (Atlanta, GA) at egg passage levels
13 and 6, respectively. Nucleotide sequences of segments
encoding HA and NA/NB of B/Victoria/504/2000 and B/
Beijing/184/93 are available in GenBank (accession numbers
AY504602, AY504604, AJ784043 and AJ784090, respec-
tively). Nucleotide sequences of other genome segments of B/
Victoria/504/2000 were also determined in our laboratory and
deposited in GenBank (Lugovtsev et al., 2005).
All mutant viruses, containing AA substitutions in the HA
molecule, were generated by reverse genetics technology and
passed three times through eggs (see Developing plasmids
encoding viral genome segment and rescue of the viruses). The
first set of mutant viruses, designated as variants ##1–7, and 10,
are viruses containing all gene segments from B/Victoria/504/
2000, but differing from B/Victoria/504/2000 by AA substitu-
tion in HA at positions 141, 162 and 196. The numbering of AA
in HA amino acid sequence is aligned to that of the prototype
strain B/Lee/40. Nucleotide sequences of all segments of virus
variant #1 are identical to the corresponding consensussequences of the original reference strain B/Victoria/504/
2000. The second set of mutant viruses, designated as variants
##43–48, 50, 52, 54 and 56, are also viruses containing all gene
segments from B/Victoria/504/2000, but with AA substitutions
in HA at positions 126, 129, 137, 141, 162 and 196. The third
set of mutant viruses, designated as variants ##14, 71–78, are
2:6 reassortants possessing HA and NA/NB gene segments
from B/Beijing/184/93 and the six other segments from
B/Victoria/504/2000. Nucleotide sequences of HA and NA/
NB gene segments of variant #14 are identical to the corres-
ponding consensus sequences of the original strain B/Beijing/
184/93. Variants ##71–78 differed from variant #14 by AA
substitutions in HAmolecule at positions 126, 129, 137 and 141.
For virus propagation and titration, 11-day old embryonated
chicken eggs (eggs) and MDCK cells were used. For reverse
genetics rescue of viruses, 293T and MDCK cells were used.
MDCK and 293T cell cultures were obtained from the
American Type Culture Collection (Manassas, VA) and were
maintained in minimal essential medium (MEM) supplemented
with 10% fetal calf serum (FCS) at 37 °C in an atmosphere with
5% CO2.
Developing plasmids encoding viral genome segment and
rescue of the viruses
A previously described technique was used to generate B/
Victoria/504/2000 variants by reverse genetics (Hoffmann et al.,
2000, 2002). Briefly, cDNA from each of the eight viral RNA
segments was amplified by PCR, using high fidelity PfuUltra
DNA polymerase (Strategene, La Jolla, CA) and the amplifica-
tion products were cloned individually into a PolI/PolII ex-
pression plasmid pHW2000 (Hoffmann et al., 2000), kindly
provided by Dr. R. G. Webster (Division of Virology, Depart-
ment of Infectious Diseases, St. Jude Children's Research Hos-
pital, Memphis, TN). All cloned viral genome segments were
sequenced and compared to the corresponding consensus
sequences, previously published by our laboratory (Lugovtsev
et al., 2005). To generate viruses with specific AA substitutions
in HA, corresponding mutations were introduced into the cloned
HA viral gene segment. Plasmids containing gene segments
from B/Beijing/184/93 were made separately by the same
procedures. Eight appropriate plasmids were used to transfect a
co-culture of 293T/MDCK cells with TransIT LT1 Reagents
(Mirus, Madison, WI). The transfected cell culture supernatants
were collected periodically from the second day after
transfection, tested for hemagglutinating activity and used to
infect 11-day old eggs. The infected eggs were incubated at
33 °C for 3 days, and the allantoic fluids were collected and
stored in aliquots at−70 °C. Each rescued virus was passed three
times in eggs before the nucleotide sequences of its HA and NA/
NB segments were analyzed to confirm the expected sequences.
Specific antisera
Antisera used in this study were obtained from ferrets (one
animal per strain), 3 weeks after intranasal inoculation with 103–
105 EID50 of a corresponding virus. For use in hemagglutination
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destroying enzyme from Vibrio cholerae (RDE, Denka Seiken
Co, Ltd., Japan) to inactivate nonspecific serum inhibitors.
Titration of viral infectivity in eggs and MDCK
Infectivity in eggs (EID50) was determined by inoculating
eggs with 0.2 ml of 10-fold dilutions of allantoic fluid (5
eggs per dilution). After incubation at 33 °C for 72 h, the
presence of virus was determined by hemagglutination. The
hemagglutination titer (HA titer) was measured by standard
method using 0.5% chicken red blood cells (RBC) in
phosphate-buffered saline (PBS, pH 7.2) (Palmer et al.,
1975). The values of HA titers were determined as an
average from 10 eggs. To determine virus infectivity in
MDCK (TCID50) cells grown to confluence in 96-well plates
were washed with PBS and inoculated with serial 10 fold
dilutions of virus (eight replicates for each sample). After one
hour at 37 °C, MDCK cells were washed and fresh medium
with 5% FCS was added. The endpoint for calculation of
TCID50 was cytopathic effect (CPE) after the incubation of
the inoculated cells for 7 days at 33 °C in an atmosphere with
5% CO2. ID50 titers were calculated by the method of Reed
and Muench (1938).
Estimation of the virus growth phenotype
Growth characteristics of the viruses were estimated by the
level of their accumulation in the allantoic fluids of eggs.
Briefly, 11-day old eggs were inoculated with 103 EID50 of
virus. After 36, 48 and 72 h post-infection, allantoic fluids were
collected and tested for hemagglutination titers and infectivity
in eggs and MDCK as described above. The mean values of
hemagglutination titers and infectivity for samples collected at
the pick of virus replication were used for comparison of the
viruses.
Determination of plaque phenotype
MDCK grown to confluence in 6 or 12 well plates were
washed with PBS and inoculated with serial 10-fold dilutions of
virus. After 1 h at 37 °C, cells were washed and overlaid with
MEM containing 0.75% agarose without exogenous trypsin.
Cells were incubated at 33 °C for 72 h, fixed with ice-cold
methanol and stained with 1% crystal violet for plaque counting
and measuring. The average plaque size was calculated as an
arithmetic mean of the sizes of 20 or more individual plaques.
Viruses that formed plaques of average size ≤1.0 mm, 1.0–
1.9 mm or ≥2.0 mm in diameter were designated as viruses
with small-size, medium-size and large-size plaque phenotype,
respectively.
Antigenic characterization
The hemagglutination inhibition (HI) test was performed in
96-well plates (four replicates for each serum sample) by
standard method (Palmer et al., 1975) using 0.5% chicken RBCin PBS (pH 7.2) and sera treated with RDE as described above.
Two viruses were considered antigenically indistinguishable if
HI titers of the corresponding antiserum for these two viruses
did not exceed two-fold difference.
Statistical analysis
A two-tailed Student's t test was used to determine statis-
tically significant differences. Differences were considered
significant if the P value is <0.05.
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